-
@ellaturnereditor·Companion Diagnostics Development Services Market Growth
Roots Analysis reports the companion diagnostics development services market is anticipated to grow at a CAGR of over 10%. These tests improve success rates of late-stage trials.
-
@ellaturnereditor·
Cell Invasion and Migration Assays Market Report
Market research report examining the market for cell invasion and migration assays from 2022-2035 from Roots Analysis.
-
@ellaturnereditor·
Soft Tissue Sarcoma Market Projected to Reach USD 420 Million by 2030
Roots Analysis projects the Soft Tissue Sarcoma market to exceed USD 420 Million by 2030, with a report focusing on Angiosarcoma, Chondrosarcoma, and Liposarcoma.
-
@ellaturnereditor·
Contract Regulatory Affairs for Medical Devices Market Analysis
Roots Analysis provides a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices.
-
@ellaturnereditor·
Cell Line Development and Characterization Services: Challenges and…
Explores the demand for recombinant proteins and cellular systems in biomedical research and therapies, highlighting the need for stable cell line development.
-
@ellaturnereditor·
Growth in Remote Patient Monitoring Market
This article discusses the growth of the remote patient monitoring market attributed to the COVID-19 pandemic and endorsement from regional governments.
-
@ellaturnereditor·
Top Selling Biologics Market: Current Landscape and Future Potential
Features an extensive study of the current market landscape and future potential of top-selling biologics used for treating various disease indications.
-
@ellaturnereditor·
Stem Cell Therapy Market Analysis
The stem cell therapy market has gained traction. There are multiple approved products and several companies are advancing their proprietary therapy candidates.
-
@ellaturnereditor·
Patient Recruitment and Retention Services Market
An increasing demand for participants in clinical research studies has prompted drug/therapy developers to outsource patient recruitment to specialty service providers.
-
@ellaturnereditor·
Cell & Gene Therapy Bioassay Services Market Analysis
Roots Analysis helps companies in the cell and gene therapy bioassay services field compare their capabilities and identify ways to gain a competitive edge.
-
@ellaturnereditor·
Progressive Supranuclear Palsy (PSP): Research and Challenges
Progressive Supranuclear Palsy (PSP) is a debilitating disease that affects the neuroscience community. Over 2,000 research studies, but there is no cure.
-
@ellaturnereditor·
Rising Need of Large Volume Wearable Injectors
The demand for large-volume wearable injectors is rising due to increased incidence of chronic diseases and novel drug delivery systems.
-
@ellaturnereditor·
Soft Tissue Sarcoma Treatment: Market and Pipeline Review
Extensive report on marketed, clinical, and preclinical molecules for the treatment of soft tissue sarcoma is available.
-
@ellaturnereditor·
CAR-T Cell Therapies Market by Target Indications
Cancer is a leading cause of death worldwide. CAR-T cell therapies offer treatment options, with newly diagnosed cancer cases anticipated to grow significantly.
-
@ellaturnereditor·
Wearable Injectors Market Analysis
Roots Analysis provides market research on evolving dynamics of large volume wearable injectors and challenges of high volume formulations.
-
@ellaturnereditor·
The Significant Potential of Gut Flora: Human Microbiome
Discover the significant potential of human microbiome and its beneficial microbial colonies, which have been known to co-exist in mutually beneficial relationships.
-
@ellaturnereditor·
ADCs: The Excitement Continues to Build
So, another round of the World ADCs just concluded. With a stellar line up that included Alain Beck from Pierre Fabre, Thorsten Sperber from Immunomedics, Nicholas Choong form Seattle Genetics, Rakesh Dixit from BioNavigen, Trevor Hallam from Sutro…
-
@ellaturnereditor·
-
@ellaturnereditor·
Cell Therapy Manufacturing Market to Reach USD 10 Billion by 2030
The cell therapy manufacturing market is expected to grow by over 20% annually, reaching nearly USD 10 billion by 2030. Increased interest from pharma stakeholders in cell therapies and outsourcing manufacturing operations are key drivers.
